AI, Biotech & Health: Where Innovation Meets Investing

Summary

In this episode, Catherine and Melissa are joined by Eden Rahim, a Portfolio Manager at Next Edge Capital. We explore the dynamic world of biotech investing, the impact of AI on medicine development, and advanced options trading strategies. We discuss recent breakthroughs in Alzheimer's treatment, CRISPR technology, and how to generate yield through options, providing valuable insights for investors and health enthusiasts alike.

Chapters

00:00 Introduction and guest background

01:11 History of biotech industry and cycles

04:36 Biotech market recovery and current outlook

06:07 Factors causing biotech volatility

07:43 What is biotech and how it differs from pharma

09:43 Blockbuster drugs and their impact on biotech

11:51 M&A activity and industry growth

16:06 Recent developments in Alzheimer's treatments

18:16 Ownership and development of Alzheimer's drugs